A first-of-its-kind hearing in Texas will determine how future court cases linking SSRIs with congenital malformation will be handled. Pfizer, the manufacturer of Zoloft, is arguing that birth defects cannot occur as a direct result of a mother’s Zoloft use during pregnancy.
Landmark Zoloft MDL Hearing To Determine Future Litigation Regarding The Connection Between Zoloft And Birth Defects (Digital Journal)
***
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
***
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.
